226 related articles for article (PubMed ID: 16439459)
1. Regulation of Graves' hyperthyroidism with naturally occurring CD4+CD25+ regulatory T cells in a mouse model.
Saitoh O; Nagayama Y
Endocrinology; 2006 May; 147(5):2417-22. PubMed ID: 16439459
[TBL] [Abstract][Full Text] [Related]
2. CD8+CD122+ T cells, a newly identified regulatory T subset, negatively regulate Graves' hyperthyroidism in a murine model.
Saitoh O; Abiru N; Nakahara M; Nagayama Y
Endocrinology; 2007 Dec; 148(12):6040-6. PubMed ID: 17823258
[TBL] [Abstract][Full Text] [Related]
3. The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells.
McLachlan SM; Nagayama Y; Pichurin PN; Mizutori Y; Chen CR; Misharin A; Aliesky HA; Rapoport B
Endocrinology; 2007 Dec; 148(12):5724-33. PubMed ID: 17823263
[TBL] [Abstract][Full Text] [Related]
4. TSH receptor-adenovirus-induced Graves' hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1/Th2 paradigm.
Nagayama Y; Saitoh O; McLachlan SM; Rapoport B; Kano H; Kumazawa Y
Clin Exp Immunol; 2004 Dec; 138(3):417-22. PubMed ID: 15544617
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility rather than resistance to hyperthyroidism is dominant in a thyrotropin receptor adenovirus-induced animal model of Graves' disease as revealed by BALB/c-C57BL/6 hybrid mice.
Chen CR; Aliesky H; Pichurin PN; Nagayama Y; McLachlan SM; Rapoport B
Endocrinology; 2004 Nov; 145(11):4927-33. PubMed ID: 15284197
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus encoding the thyrotropin receptor A-subunit improves the efficacy of dendritic cell-induced Graves' hyperthyroidism in mice.
Mizutori Y; Saitoh O; Eguchi K; Nagayama Y
J Autoimmun; 2006 Feb; 26(1):32-6. PubMed ID: 16242303
[TBL] [Abstract][Full Text] [Related]
7. Enhanced response to mouse thyroid-stimulating hormone (TSH) receptor immunization in TSH receptor-knockout mice.
Nakahara M; Mitsutake N; Sakamoto H; Chen CR; Rapoport B; McLachlan SM; Nagayama Y
Endocrinology; 2010 Aug; 151(8):4047-54. PubMed ID: 20555026
[TBL] [Abstract][Full Text] [Related]
8. Low-dose immunization with adenovirus expressing the thyroid-stimulating hormone receptor A-subunit deviates the antibody response toward that of autoantibodies in human Graves' disease.
Chen CR; Pichurin P; Chazenbalk GD; Aliesky H; Nagayama Y; McLachlan SM; Rapoport B
Endocrinology; 2004 Jan; 145(1):228-33. PubMed ID: 14576177
[TBL] [Abstract][Full Text] [Related]
9. A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor.
Nagayama Y; Kita-Furuyama M; Ando T; Nakao K; Mizuguchi H; Hayakawa T; Eguchi K; Niwa M
J Immunol; 2002 Mar; 168(6):2789-94. PubMed ID: 11884447
[TBL] [Abstract][Full Text] [Related]
10. Insight into Graves' hyperthyroidism from animal models.
McLachlan SM; Nagayama Y; Rapoport B
Endocr Rev; 2005 Oct; 26(6):800-32. PubMed ID: 15827111
[TBL] [Abstract][Full Text] [Related]
11. Prevention of autoantibody-mediated Graves'-like hyperthyroidism in mice with IL-4, a Th2 cytokine.
Nagayama Y; Mizuguchi H; Hayakawa T; Niwa M; McLachlan SM; Rapoport B
J Immunol; 2003 Apr; 170(7):3522-7. PubMed ID: 12646613
[TBL] [Abstract][Full Text] [Related]
12. Probing the genetic basis for thyrotropin receptor antibodies and hyperthyroidism in immunized CXB recombinant inbred mice.
Aliesky HA; Pichurin PN; Chen CR; Williams RW; Rapoport B; McLachlan SM
Endocrinology; 2006 Jun; 147(6):2789-800. PubMed ID: 16543368
[TBL] [Abstract][Full Text] [Related]
13. Schistosoma mansoni and alpha-galactosylceramide: prophylactic effect of Th1 Immune suppression in a mouse model of Graves' hyperthyroidism.
Nagayama Y; Watanabe K; Niwa M; McLachlan SM; Rapoport B
J Immunol; 2004 Aug; 173(3):2167-73. PubMed ID: 15265954
[TBL] [Abstract][Full Text] [Related]
14. Differential Susceptibility of BALB/c and BALB/cBy mice to Graves' hyperthyroidism.
Seetharamaiah GS; Land KJ
Thyroid; 2006 Jul; 16(7):651-8. PubMed ID: 16889488
[TBL] [Abstract][Full Text] [Related]
15. Impairment of regulatory capacity of CD4+CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves' disease.
Mao C; Wang S; Xiao Y; Xu J; Jiang Q; Jin M; Jiang X; Guo H; Ning G; Zhang Y
J Immunol; 2011 Apr; 186(8):4734-43. PubMed ID: 21398613
[TBL] [Abstract][Full Text] [Related]
16. Distinct role of T helper Type 17 immune response for Graves' hyperthyroidism in mice with different genetic backgrounds.
Horie I; Abiru N; Saitoh O; Ichikawa T; Iwakura Y; Eguchi K; Nagayama Y
Autoimmunity; 2011 Mar; 44(2):159-65. PubMed ID: 20670120
[TBL] [Abstract][Full Text] [Related]
17. Induction of murine neonatal tolerance against Graves' disease using recombinant adenovirus expressing the TSH receptor A-subunit.
Wu L; Xun L; Yang J; Xu L; Tian Z; Gao S; Zhang Y; Hou P; Shi B
Endocrinology; 2011 Mar; 152(3):1165-71. PubMed ID: 21285313
[TBL] [Abstract][Full Text] [Related]
18. Thyrotropin Receptor-Specific Lymphocytes in Adenovirus-TSHR-Immunized Native and Human Leukocyte Antigen-DR3-Transgenic Mice and in Graves' Disease Patient Blood.
Degen H; Gavvovidis I; Blankenstein T; Uhland K; Ungerer M
Thyroid; 2021 Jun; 31(6):950-963. PubMed ID: 33208049
[No Abstract] [Full Text] [Related]
19. Differential requirement of signal transducer and activator of transcription-4 (Stat4) and Stat6 in a thyrotropin receptor-289-adenovirus-induced model of Graves' hyperthyroidism.
Land KJ; Gudapati P; Kaplan MH; Seetharamaiah GS
Endocrinology; 2006 Jan; 147(1):111-9. PubMed ID: 16195404
[TBL] [Abstract][Full Text] [Related]
20. An improved Graves' disease model established by using in vivo electroporation exhibited long-term immunity to hyperthyroidism in BALB/c mice.
Kaneda T; Honda A; Hakozaki A; Fuse T; Muto A; Yoshida T
Endocrinology; 2007 May; 148(5):2335-44. PubMed ID: 17255207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
